Anti-Müllerian Hormone (AMH)

Hormones

Female Hormones

Anti-Mullerian Hormone (AMH) is produced by developing ovarian follicles and serves as a marker of ovarian reserve, reflecting the remaining egg supply. It is one of the more stable ovarian markers across the menstrual cycle. Longevity and preventive practices track it to inform reproductive planning and to gauge where a woman sits on the timeline toward menopause.

What It Measures

Ovarian reserve marker; reflects remaining egg supply

Optimal vs. Lab Range

Longevity Optimal

Age-dependent; declining is normal

Target range for optimal health and longevity based on research.

Standard Lab

1.0–3.5 ng/mL (reproductive age)

Population-based reference range from standard labs.

Why It Matters

AMH offers a forward-looking estimate of reproductive potential that other hormones capture less directly. A declining level is a normal, age-related process, but a low result for one's age can indicate diminished ovarian reserve, premature ovarian insufficiency, or an approaching menopausal transition. Elevated AMH is often seen in PCOS. Because a gradual decline is expected, results are interpreted against age-based expectations and alongside FSH, estradiol, and antral follicle count. Beyond fertility, understanding this trajectory helps guide timely conversations about bone, cardiovascular, and hormonal health as estrogen changes approach.

When Low

Diminished ovarian reserve, premature ovarian insufficiency, approaching menopause

When High

PCOS (often elevated)

How to Optimize

AMH itself is not a number to raise; instead, it informs planning. For those prioritizing fertility, timely conversations about fertility preservation are the most meaningful step, and options such as CoQ10 or physician-directed DHEA are sometimes discussed in that context. The value lies in using the result to guide decisions rather than to chase a target. Hormone testing and treatment must be individualized with your physician; this content is educational and not a substitute for medical advice.

Key Interventions & Linked Compounds

Moderate evidence

Key Interventions

Fertility preservation

CoQ10

DHEA (clinical)

Linked Compounds & Supplements

CoQ10

DHEA

Myo-inositol

Vitamin D

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Serum; saliva for diurnal cortisol panels

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Annual

Reporting unit

Confirm with the performing lab — units vary by region.

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Anti-Müllerian Hormone (AMH).
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.